Quotient Sciences

CDMO/CRDMO with 35+ years of experience, pioneer in integrating CRO and CDMO services through its Translational Pharmaceutics® platform that combines drug product manufacturing and clinical testing to reduce costs and timelines by up to 12 months. Clinical units in Miami, FL and Nottingham, UK, with 30,000+ healthy volunteer database. Acquired Arcinova (northeast England CDMO) in 2021. Specialized technologies: solubility enhancement, modified release, pediatric, HPAPIs and oral peptides.